Evidence map›Paper›PMID 20705427›Full record

SynthesisJournal of clinical epidemiology2011

Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials.

David D Rahn, Husam Abed, Vivian W Sung, Kristen A Matteson, Rebecca G Rogers, Michelle Y Morrill, Matthew D Barber, Joseph I Schaffer, Thomas L Wheeler, Ethan M Balk and 2 more

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of clinical epidemiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Uterine artery embolization for symptomatic uterine fibroids.The Cochrane database of systematic reviews · 2014
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Medroxyprogesterone Acetate for Abnormal Uterine Bleeding Due to Ovulatory Dysfunction: The Effect of 2 Different-Duration Regimens.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Article
  8. Article
  9. Menstruation: science and society.American journal of obstetrics and gynecology · 2020
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David D RahnUniversity of Texas Southwestern Medical Center, Dallas, TX, USA. David.Rahn@utsouthwestern.edu
Husam Abed
Vivian W Sung
Kristen A Matteson
Rebecca G Rogers
Michelle Y Morrill
Matthew D Barber
Joseph I Schaffer
Thomas L Wheeler
Ethan M Balk
Katrin Uhlig
Society of Gynecologic Surgeons-Systematic Review Group

Funding

A Comprehensive Patient Based Outcome Measure for Heavy Menstral BleedingK23HD057957 · NICHD · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI MATTESON, KRISTEN A · 2008 to 2012
$797k
NICHD NIH HHS K23 HD057957
6 · The paper itself

Abstract

objectives(1) To systematically collect and organize into clinical categories all outcomes reported in trials for abnormal uterine bleeding (AUB); (2) to rank the importance of outcomes for patient decision making; and (3) to improve future comparisons of effects in trials of AUB interventions. STUDY DESIGN AND

settingSystematic review of English-language randomized controlled trials of AUB treatments in MEDLINE from 1950 to June 2008. All outcomes and definitions were extracted and organized into major outcome categories by an expert group. Each outcome was ranked "critically important," "important," or "not important" for informing patients' choices.

resultsOne hundred thirteen articles from 79 trials met the criteria. One hundred fourteen different outcomes were identified, only 15 (13%) of which were ranked as critically important and 29 (25%) as important. Outcomes were grouped into eight categories: (1) bleeding; (2) quality of life; (3) pain; (4) sexual health; (5) patient satisfaction; (6) bulk-related complaints; (7) need for subsequent surgical treatment; and (8) adverse events.

conclusionTo improve the quality, consistency, and utility of future AUB trials, we recommend assessing a limited number of clinical outcomes for bleeding, disease-specific quality of life, pain, sexual health, and bulk-related symptoms both before and after treatment and reporting satisfaction and adverse events. Further development of validated patient-based outcome measures and the standardization of outcome reporting are needed.

Indexed as

EndometriumFemaleHumansLeiomyomaOutcome Assessment, Health CarePatient SatisfactionQuality of LifeRandomized Controlled Trials as TopicSalvage TherapyTreatment OutcomeUnited StatesUterine Artery EmbolizationUterine HemorrhageUterine Neoplasms

Identifiers

PMID20705427
PMCPMC3057176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.